Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin in Pulmonary Tuberculosis
NCT03160638Phase 2Completed
- Sponsor
- University Medical Center Groningen
- Start
- Feb 2018
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azithromycin in Tuberculosis (TB), sponsored by University Medical Center Groningen. Started Feb 2018; status: completed.
02
Drugs
azithromycin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT03160638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03160638.